Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Naftali Bennett replaces Benjamin Netanyahu as Israeli Prime Minister

In a victory decided by one vote, Benjamin Netanyahu has…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Hospital Suspends 200 Workers Who Refused Vaccine

A hospital in Houston, Texas has suspended over 200 workers…
Read more

Christian Alternative to Boy Scouts Sees Growth

A Christian alternative to the Boy Scouts of America has experienced…
Read more